Heterocyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device
US-2024373662-A1 · Nov 7, 2024 · US
US9231218B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9231218-B2 |
| Application number | US-201313798935-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 13, 2013 |
| Priority date | Jul 10, 2012 |
| Publication date | Jan 5, 2016 |
| Grant date | Jan 5, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A dibenzo[1,4]azaborine comprising compound, and devices and formulations including the same are described. The compound includes a ligand L 1 including wherein E 1 is N; E 2 is B; and R 3 and R 4 represent mono, di, tri, tetra substitutions or no substitution; wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two adjacent R 1 , R 2 , R 3 , and R 4 are optionally joined to form a ring, which may be further substituted; wherein L 1 is coordinated to a metal M, provided that the metal M does not form bond with E 1 and E 2 ; and wherein L 1 may be linked with other ligands to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand.
Opening claim text (preview).
We claim: 1. A compound comprising a first ligand L 1 ; wherein L 1 comprises the following formula: wherein E 1 is N; wherein E 2 is B; wherein R 3 and R 4 represent mono, di, tri, tetra substitutions or no substitution; wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two adjacent R 1 , R 2 , R 3 , and R 4 are optionally joined to form a ring, which may be further substituted; wherein (i) at least one R 1 , R 2 , R 3 , or R 4 is a 5-or 6-membered heteroaryl ring A containing a nitrogen, (ii) at least one pair of adjacent substituents R 1 , R 2 , R 3 , and R 4 form a fused ring B that includes E 1 or E 2 , or (iii) both (i) and (ii); wherein ring A, ring B, or both ring A and ring B are coordinated to metal M; wherein ring A and ring B can be further substituted; wherein L 1 is coordinated to a metal M, provided that the metal M does not form bond with E 1 and E 2 ; and wherein L 1 may be linked with other ligands to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand. 2. The compound of claim 1 , wherein the metal M is a metal selected from the group consisting of Ir, Pt, Re, Os, Ru, Rh, Pd, Cu, Ag, and Au. 3. The compound of claim 1 , wherein the metal M is Ir. 4. The compound of claim 1 , wherein the metal M is Pt. 5. The compound of claim 1 , wherein at least one of R 1 and R 2 is aryl or substituted aryl. 6. The compound of claim 5 , wherein at least one of R 1 and R 2 is phenyl, or 2,6-disubstituted phenyl. 7. The compound of claim 1 , wherein the compound is homoleptic. 8. The compound of claim 1 , wherein the compound is heteroleptic. 9. The compound of claim 8 , wherein the compound comprises a second ligand L 2 ; wherein the ligand L 2 or part of the ligand L 2 if the ligand is more than bidentate is selected from the group consisting of: wherein R a , R b , R c , and R d may represent mono, di, tri, or tetra substitution, or no substitution; wherein R a , R b , R c , and R d are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein two adjacent substituents of R a , R b , R c , and R d are optionally joined to form a fused ring or form a multidentate ligand. 10. The compound of claim 1 , wherein the compound having the formula: wherein L 2 is a second ligand coordinated to the metal M; wherein each L 2 can be same or different; wherein m is a value from 1 to the maximum number of ligands that may be attached to the metal M; wherein m+n is the maximum number of ligands that may be attached to the metal M; and wherein any of R 1 , R 2 , and R 3 are optionally linked to L 2 to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand. 11. The compound of claim 10 , wherein at least one of R 1 , R 2 , and R 3 are linked to L 2 to comprise a bidentate, tridentate, tetradentate, pentadentate or hexadentate ligand. 12. The compound of claim 10 , wherein the compound is selected from the group consisting of: wherein X 1 , X 2 is selected from the group consisting of C, N, O, P, S, and B; wherein A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; wherein R 5 represents mono, di, tri, tetra substitutions or no substitution; wherein R 5 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent R 1 , R 2 , R 3 , R 4 , and R 5 are optionally joined to form a ring, which may be further substituted. 13. The compound of claim 12 , wherein A is selected from the group consisting of: wherein Y is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′; wherein R, R′ are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein R, R′ are optionally joined to form a ring with any adjacent substituent. 14. The compound of claim 10 , wherein the compound is selected from the group consisting of: 15. The compound of claim 14 , wherein m is 3, and n is 0. 16. The compound of claim 14 , wherein m is 1, and n is 2. 17. The compound of claim 14 , wherein L 2 is selected from the group consisting of: 18. The compound of claim 10 , wherein the compound is selected from the group consisting of:
Organoboranes · CPC title
comprising platinum · CPC title
containing organic luminescent materials · CPC title
characterised by the chemical or physical composition or the arrangement of the electroluminescent material {, or by the simultaneous addition of the electroluminescent material in or onto the light source} · CPC title
containing one nitrogen atom as the heteroatom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.